Literature DB >> 15073337

The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase.

Attila Mócsai1, Mary Beth Humphrey, Jessica A G Van Ziffle, Yongmei Hu, Andrew Burghardt, Steven C Spusta, Sharmila Majumdar, Lewis L Lanier, Clifford A Lowell, Mary C Nakamura.   

Abstract

Osteoclasts, the only bone-resorbing cells, are central to the pathogenesis of osteoporosis, yet their development and regulation are incompletely understood. Multiple receptors of the immune system use a common signaling paradigm whereby phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) within receptor-associated adapter proteins recruit the Syk tyrosine kinase. Here we demonstrate that a similar mechanism is required for development of functional osteoclasts. Mice lacking two ITAM-bearing adapters, DAP12 and the Fc receptor gamma-chain (FcRgamma), are severely osteopetrotic. DAP12(-/-)FcRgamma(-/-) bone marrow cells fail to differentiate into multinucleated osteoclasts or resorb bone in vitro and show impaired phosphorylation of the Syk tyrosine kinase. syk(-/-) progenitors are similarly defective in osteoclast development and bone resorption. Intact SH2-domains of Syk, introduced by retroviral transduction, are required for functional reconstitution of syk(-/-) osteoclasts, whereas intact ITAM-domains on DAP12 are required for reconstitution of DAP12(-/-) FcRgamma(-/-) cells. These data indicate that recruitment of Syk to phosphorylated ITAMs is critical for osteoclastogenesis. Although DAP12 appears to be primarily responsible for osteoclast differentiation in cultures directly stimulated with macrophage-colony stimulating factor and receptor activator of NF-kappaB ligand cytokines, DAP12 and FcRgamma have overlapping roles in supporting osteoclast development in osteoblast-osteoclast cocultures, which mirrors their overlapping functions in vivo. These results provide new insight into the biology of osteoclasts and suggest novel therapeutic targets in diseases of bony remodeling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073337      PMCID: PMC395939          DOI: 10.1073/pnas.0401602101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

2.  Osteoblast isolation from murine calvariae and long bones.

Authors:  Astrid Bakker; Jenneke Klein-Nulend
Journal:  Methods Mol Med       Date:  2003

3.  DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase.

Authors:  D W McVicar; L S Taylor; P Gosselin; J Willette-Brown; A I Mikhael; R L Geahlen; M C Nakamura; P Linnemeyer; W E Seaman; S K Anderson; J R Ortaldo; L H Mason
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

6.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.

Authors:  M Turner; P J Mee; P S Costello; O Williams; A A Price; L P Duddy; M T Furlong; R L Geahlen; V L Tybulewicz
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

7.  c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.

Authors:  S Tanaka; M Amling; L Neff; A Peyman; E Uhlmann; J B Levy; R Baron
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

8.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

9.  DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.

Authors:  Juha Paloneva; Jami Mandelin; Anna Kiialainen; Tom Bohling; Johannes Prudlo; Panu Hakola; Matti Haltia; Yrjo T Konttinen; Leena Peltonen
Journal:  J Exp Med       Date:  2003-08-18       Impact factor: 14.307

10.  Impaired differentiation of osteoclasts in TREM-2-deficient individuals.

Authors:  Marina Cella; Cecilia Buonsanti; Carey Strader; Takayuki Kondo; Andrea Salmaggi; Marco Colonna
Journal:  J Exp Med       Date:  2003-08-11       Impact factor: 14.307

View more
  175 in total

1.  An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.

Authors:  Laura A Maile; Victoria E DeMambro; Christine Wai; Sutada Lotinun; Ariel W Aday; Byron E Capps; Wesley G Beamer; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

2.  Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes.

Authors:  Se Hwan Mun; Na Young Ko; Hyuk Soon Kim; Jie Wan Kim; Do Kyun Kim; A-Ram Kim; Seung Hyun Lee; Yong-Gil Kim; Chang Keun Lee; Seoung Hoon Lee; Bo Kyung Kim; Michael A Beaven; Young Mi Kim; Wahn Soo Choi
Journal:  Cell Mol Life Sci       Date:  2010-06-08       Impact factor: 9.261

3.  The transmembrane adaptor protein, linker for activation of T cells (LAT), regulates RANKL-induced osteoclast differentiation.

Authors:  Kabsun Kim; Jung Ha Kim; Jang Bae Moon; Jongwon Lee; Han Bok Kwak; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 4.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 5.  The skeletal subsystem as an integrative physiology paradigm.

Authors:  Aaron J Weiss; Jameel Iqbal; Neeha Zaidi; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

Review 6.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

7.  Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts.

Authors:  Wei Zou; Tingting Zhu; Clarissa S Craft; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2010-09-01       Impact factor: 5.285

8.  A bone to pick with Fc gamma receptors.

Authors:  Christian M Karsten; Jörg Köhl
Journal:  Ann Transl Med       Date:  2015-09

Review 9.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

Review 10.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.